Skip to main
ATNM
ATNM logo

Actinium Pharmaceuticals (ATNM) Market Capitalization Overview

Market Cap: $46.49M as of Jun 13, 2025

$46.49M
Past Month-$1.25M (2.61%)
As of Jun 13, 2025, Actinium Pharmaceuticals (ATNM) has a market capitalization of $46.49M. Over the past 30 days, its market cap has increased by 8.72%, while in the last 12 months, it has increased by 18.25%.

Market capitalization represents the total value of Actinium Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Actinium Pharmaceuticals (ATNM) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Actinium Pharmaceuticals (ATNM) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Actinium Pharmaceuticals (ATNM) Market Cap History

DateMarket CapChange
Jun 2, 2025$50.54M+8.72%
May 1, 2025$46.49M0.00%
Apr 1, 2025$46.49M+40.57%
Mar 3, 2025$33.07M-10.17%
Feb 3, 2025$36.82M-6.35%
Jan 2, 2025$39.31M-10.64%

Actinium Pharmaceuticals (ATNM) End of Year Market Cap History

DateMarket CapChange
2025$46.49M+18.25%
2024$39.31M-71.77%
2023$139.27M-48.69%
2022$271.40M+104.97%
2021$132.41M+24.94%
2020$105.98M

FAQs About Actinium Pharmaceuticals (ATNM) Market Cap

As of Jun 13, 2025, the market capitalization of Actinium Pharmaceuticals (ATNM) is $46.49M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Actinium Pharmaceuticals’s market capitalization has decreased by -2.61%, changing from $47.73M to $46.49M as of Jun 13, 2025.

In the last 3 months, Actinium Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Actinium Pharmaceuticals’s market capitalization decreased from $139.27M in January to $39.31M in December, reflecting a -71.77% change.

In the past five years, Actinium Pharmaceuticals (ATNM) has had a compound annual growth rate (CAGR) of -17.99% in market capitalization. This means its market cap has shrunk at an average rate of -17.99% per year.

Actinium Pharmaceuticals (ATNM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.